Robert B. Geller - 01 Jul 2022 Form 4 Insider Report for Aravive, Inc.

Role
Chief Medical Officer
Signature
/s/ Robert B. Geller
Issuer symbol
N/A
Transactions as of
01 Jul 2022
Net transactions value
$0
Form type
4
Filing time
05 Jul 2022, 16:06:46 UTC
Next filing
02 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARAV Stock Option Award $0 +200,000 $0.000000 200,000 01 Jul 2022 Common Stock 200,000 $0.9340 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying the option vest on the 12 month anniversary of the grant date and the remaining 75% vest in equal monthly installments over the next 36 months of continuous service.